Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-16

Clinical Trial Update: Efficacy of Dolasetron in Patients With Fibromyalgia [Phase 3]

View source ↗

Summary

A phase 3 study evaluated dolasetron for fibromyalgia. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolasetron (dolasetron)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED